Author: Bill Snyder
Jun. 17, 2020—The next virtual forum on diversity and inclusion for the Vanderbilt University Medical Center community will be held from 9-10 a.m. Tuesday, June 23.
Jun. 11, 2020—Led by André Churchwell, MD, Vice Chancellor of Equity, Diversity and Inclusion at Vanderbilt University and Chief Diversity Officer at VUMC, the hour-long conversation, spurred by the nation grappling with the death of George Floyd and other black Americans, was meant to encourage members of the VUMC community to discuss racism and unconscious bias, and offer an opportunity to support and engage with each other during this particularly difficult time.
Jun. 10, 2020—The nation is now focused on the deaths of black citizens in police custody but systemic racism permeates every facet of American society including health care, according to panelists who participated in a webinar presented last week by the Vanderbilt University Medical Center Office of Health Equity.
Jun. 9, 2020—After evaluating the ability of more than 1,500 monoclonal antibodies to bind and neutralize the COVID-19 virus, SARS-CoV-2, in the laboratory, AstraZeneca signed an exclusive license to six candidate antibodies in Vanderbilt’s portfolio.
Jun. 4, 2020—The investigational antiviral drug remdesivir can shorten the time to recovery in adults hospitalized with COVID-19, according to preliminary results of a clinical trial published last month in The New England Journal of Medicine.
May. 27, 2020—Lung disease experts at Vanderbilt University Medical Center (VUMC) and their colleagues have determined a key factor as to why COVID-19 appears to infect and sicken adults and older people preferentially while seeming to spare younger children.
May. 12, 2020—William J. Stone, MD, nephrologist and professor of Medicine, emeritus, who retired in December after 50 years as a member of the faculty of the Vanderbilt University School of Medicine, died Monday, May 11, at his home in Nashville. He was 83.